Uso de anti-VEGF (anti-vascular endothelial growth factor) en la retinopatía del prematuro
- 31 July 2011
- journal article
- research article
- Published by Elsevier in Archivos de la Sociedad Española de Oftalmología
- Vol. 86 (7) , 207-208
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- Efficacy of Intravitreal Bevacizumab for Stage 3+ Retinopathy of PrematurityNew England Journal of Medicine, 2011
- Nueva técnica anestésica en el tratamiento con láser diodo de la retinopatía del prematuroAnales de Pediatría, 2008
- Acute contraction of the proliferative membrane after an intravitreal injection of bevacizumab for advanced retinopathy of prematurityGraefe's Archive for Clinical and Experimental Ophthalmology, 2008
- Revised Indications for the Treatment of Retinopathy of PrematurityArchives of Ophthalmology (1950), 2003